Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder.

Br J Cancer · 2015 · PMC4430712 · PMID 25897675

Europe PMC DOI

hedged sentence

0.7600

closest p · 15.2× alpha

0.7600

boldest claim

The sentences

did not reach statistical significanceP =0.76not close (p > 0.1)

Sub group univariate analysis demonstrated that concurrent chemotherapy did not reach statistical significance for PFS (HR 1.1 95% CI 0.5, 2.3: P =0.76), OS (HR 1.0 95% CI 0.4, 2.8: P =0.93) or DSS (HR 1.3 95% CI 0.4, 4.1: P =0.65).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.